Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
about
Translational research in diagnosis and management of soft tissue tumoursAdipophilin as prognostic biomarker in clear cell renal cell carcinoma.Identification of a gene expression driven progression pathway in myxoid liposarcoma.Axl as a mediator of cellular growth and survivalThe role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcomaPrimary subcutaneous myxoid liposarcoma: a clinicopathologic review of three cases with molecular confirmation and discussion of the differential diagnosis.Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case reportTargeting protein kinases to reverse multidrug resistance in sarcoma.Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case reportPrimary Retroperitoneal Myxoid LiposarcomasThe indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Liposarcoma: Multimodality Management and Future Targeted Therapies.Sebaceous Carcinoma of the Eyelid.Multimodality Management of Soft Tissue Tumors in the ExtremityMulti-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.Metastasis of myxoid liposarcoma to fat-bearing areas: A case report of unusual metastatic sites and a hypothesis.Is multimodality therapy necessary for the management of pure myxoid liposarcomas? A multi-institutional series of pure myxoid liposarcomas of the extremities and torso.Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma.Tyrosine Kinase Receptor Expression in Canine Liposarcoma.NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.[Isolated limb perfusion for liposarcoma : Histopathological response and subgroup analysis after TNF melphalan-based ILP].Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution.Soft Tissue Sarcoma Cancer Stem Cells: An Overview
P2860
Q26748651-04545F11-FAD8-4165-BCB5-FC2389F859DDQ33709844-0A7CE39F-3714-44B1-A741-F01FF6D40049Q34227540-9F90F73E-1B47-46F2-8B62-A1D25EDB5990Q34619118-A8A518FF-0109-46BB-976C-8B45E144C130Q35149569-B4B27F85-02D0-488C-A371-D46BD13BD256Q35400793-4F843488-4BEA-4444-AD3A-60A6FC044C62Q35619674-A8ADD5EE-B911-4402-B218-7B32747F4634Q36527950-D6AC158F-D0D9-4D62-AC56-42CDF37FBADEQ36903707-A362D0C6-616D-44E9-B188-0FF28B89C428Q37082518-844E735E-5459-4953-AA07-14C7037BB87BQ37136357-7B6669C9-2FC4-43AF-9957-C47CBF68C211Q37164989-653A0D0E-8AA8-47E9-8BD1-2E14AEBA00E5Q37268602-B0738820-6F97-48AC-A2A8-CFC586CE044FQ38315670-0E2DF539-6C95-4EB4-8896-00F363DB0961Q38824691-35976FB3-E6D2-4164-9914-4A7292254F06Q38842915-E2270D15-2C80-4708-A809-9FB0D35A0BDCQ38932249-47DC1B7D-1372-4066-AAA5-07DF3250D268Q39014708-4ED35026-945F-41A7-B691-FC6BD14796D7Q41026125-B07577D4-0F74-4D9C-9DB6-C83FF1DCE47AQ42113476-090BD475-E33A-45FD-94F6-050975169ED8Q45158427-8813F76A-8ADB-4644-9A83-11AF9E161764Q47148669-283D2ABA-0579-4EA2-A59F-2DDB22BBB730Q47244891-E646919F-F2FC-4B01-89F1-B0F0CE7EA4D2Q49592978-87170212-1C26-4688-95B5-49F698F1A35FQ51435849-27AA4023-6A01-48B0-B6EC-1106BF40C630Q53081281-7B7F70AC-E30D-4BFB-92C9-4CDB2D74D23EQ53675851-DD6BEFF1-DEBA-4B4F-870C-1BEC291DDA8AQ55427534-27787A05-8762-4DE7-A8CF-82E2AB65568FQ58707604-13725FC1-BBDC-4186-8DBD-2E5BD924F295
P2860
Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Localized and metastatic myxoi ...... al and molecular observations.
@en
Localized and metastatic myxoi ...... al and molecular observations.
@nl
type
label
Localized and metastatic myxoi ...... al and molecular observations.
@en
Localized and metastatic myxoi ...... al and molecular observations.
@nl
prefLabel
Localized and metastatic myxoi ...... al and molecular observations.
@en
Localized and metastatic myxoi ...... al and molecular observations.
@nl
P2093
P2860
P50
P356
P1433
P1476
Localized and metastatic myxoi ...... al and molecular observations.
@en
P2093
Aviad Hoffman
Chad J Creighton
Davis Ingram
Elizabeth G Demicco
Keila Torres
Kristelle Lusby
Markus P H Ghadimi
Raphael E Pollock
Tingsheng Peng
P2860
P304
P356
10.1002/CNCR.27847
P407
P577
2013-02-07T00:00:00Z